Terms: = Prostate cancer AND KIT, C-Kit, 3815, ENSG00000157404, CD117, SCFR, P10721 AND Staging
7 results:
1. [
Maurin M; Wyczółkowska M; Sawicka A; Sikora AE; Karczmarczyk U; Janota B; Radzik M; Kłudkiewicz D; Pijarowska-Kruszyna J; Jaroń A; Wojdowska W; Garnuszek P
Molecules; 2022 Oct; 27(21):. PubMed ID: 36364046
[TBL] [Abstract] [Full Text] [Related]
2. Clinical Evaluation of FOXO1 as a Tumor Suppressor in prostate cancer.
Yang N; Wu J; Zhang T; Yang F; Shao J; He C; Qin L
Comput Math Methods Med; 2021; 2021():8773423. PubMed ID: 34552661
[TBL] [Abstract] [Full Text] [Related]
3. MiR-519d inhibits prostate cancer cell proliferation, cycle and invasion via targeting NRBP1.
Yan CQ; Lu YH; Tang SM; Fan WX
Eur Rev Med Pharmacol Sci; 2018 May; 22(10):2985-2990. PubMed ID: 29863241
[TBL] [Abstract] [Full Text] [Related]
4. Optimal time-point for
Beheshti M; Paymani Z; Brilhante J; Geinitz H; Gehring D; Leopoldseder T; Wouters L; Pirich C; Loidl W; Langsteger W
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(7):1188-1196. PubMed ID: 29476228
[TBL] [Abstract] [Full Text] [Related]
5. Role of Genetic Polymorphisms in the Development and Prognosis of Sporadic and Familial prostate cancer.
Reis ST; Viana NI; Leite KR; Diogenes E; Antunes AA; Iscaife A; Nesrallah AJ; Passerotti CC; Srougi V; Pontes-Junior J; Salles ME; Nahas WC; Srougi M
PLoS One; 2016; 11(12):e0166380. PubMed ID: 27906997
[TBL] [Abstract] [Full Text] [Related]
6. Reverse transcription-polymerase chain reaction detection of prostate-specific antigen, prostate-specific membrane antigen, and prostate stem cell antigen in one milliliter of peripheral blood: value for the staging of prostate cancer.
Hara N; Kasahara T; Kawasaki T; Bilim V; Obara K; Takahashi K; Tomita Y
Clin Cancer Res; 2002 Jun; 8(6):1794-9. PubMed ID: 12060619
[TBL] [Abstract] [Full Text] [Related]
7. [Clinical evaluation of serum prostatic specific antigen in prostatic cancer: simultaneous assays of prostatic specific antigen, gamma-seminoprotein and prostatic acid phosphatase in 113 newly diagnosed patients with prostatic cancer].
Arai Y; Yoshki T; Okada K; Yoshida O; Yamamoto N; Sakatoku J; Sugimura Y; Kawamura J
Hinyokika Kiyo; 1989 Sep; 35(9):1519-28. PubMed ID: 2479237
[TBL] [Abstract] [Full Text] [Related]
